Namocatcat, Beteliano P.

HRN: 21-52-53  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
07/05/2022
07/11/2022
IV
600 Mg
Q6H
CAP-MR; T/C Aspiration Pneumonia
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: